{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:12:20Z","timestamp":1791303140861,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40123-025-01221-z","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:47:38Z","timestamp":1754660858000},"page":"2433-2442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Data of the First UK Series of MINIject Supraciliary Glaucoma Implant with 6 Months Follow-Up"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1836-772X","authenticated-orcid":false,"given":"Chrysostomos","family":"Dimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Dervenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy C. K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rynda","family":"Nitiahpapand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Chatzithanasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Lolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dervenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos","family":"Lascaratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"10108","key":"1221_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, et\u00a0al. Glaucoma. Lancet. 2017;390(10108):2183\u201393.","journal-title":"Lancet"},{"issue":"11","key":"1221_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, et\u00a0al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"12","key":"1221_CR3","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41433-021-01595-x","volume":"35","author":"ICF Pereira","year":"2021","unstructured":"Pereira ICF, van de Wijdeven R, Wyss HM, et\u00a0al. Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions. Eye (Lond). 2021;35(12):3202\u201321.","journal-title":"Eye (Lond)"},{"key":"1221_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajo.2019.07.015","volume":"208","author":"G Reiss","year":"2019","unstructured":"Reiss G, Clifford B, Vold S, et\u00a0al. Safety and effectiveness of CyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol. 2019;208:219\u201325.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1221_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.ophtha.2016.06.032","volume":"123","author":"S Vold","year":"2016","unstructured":"Vold S, Ahmed II, Craven ER, et\u00a0al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123(10):2103\u201312.","journal-title":"Ophthalmology"},{"key":"1221_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-vision-121219-081737","volume":"6","author":"DJ Mathew","year":"2020","unstructured":"Mathew DJ, Buys YM. Minimally invasive glaucoma surgery: a critical appraisal of the literature. Annu Rev Vis Sci. 2020;6:47\u201389.","journal-title":"Annu Rev Vis Sci"},{"issue":"1","key":"1221_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bjophthalmol-2020-316888","volume":"106","author":"P Denis","year":"2022","unstructured":"Denis P, Hirneiss C, Durr GM, et\u00a0al. Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol. 2022;106(1):65\u201370.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1221_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ogla.2019.06.001","volume":"2","author":"P Denis","year":"2019","unstructured":"Denis P, Hirneiss C, Reddy KP, et\u00a0al. A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma. 2019;2(5):290\u20137.","journal-title":"Ophthalmol Glaucoma"},{"issue":"10","key":"1221_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/IJG.0000000000001632","volume":"29","author":"J Garcia Feijoo","year":"2020","unstructured":"Garcia Feijoo J, Denis P, Hirneiss C, et\u00a0al. A European study of the performance and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-II). J Glaucoma. 2020;29(10):864\u201371.","journal-title":"J Glaucoma"},{"issue":"7","key":"1221_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","volume":"129","author":"IIK Ahmed","year":"2022","unstructured":"Ahmed IIK, De Francesco T, Rhee D, et\u00a0al. Long-term outcomes from the HORIZON randomized trial for a Schlemm\u2019s Canal Microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129(7):742\u201351.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01221-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:40:57Z","timestamp":1757068857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01221-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1221"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01221-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chrysostomos Dimitriou, Panagiotis Dervenis, Jeremy C.K. Tan, Caroline Wong, Luke Tanner, Rynda Nitiahpapand, Ihsan Fazal, Georgios Chatzithanasis, Dimitrios Lolos, Dimitrios Stavropoulos, Nikolaos Dervenis and Gerassimos Lascaratos have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Our study adhered to the tenets of the Declaration of Helsinki. Approval by the local Institutional Review Board (IRB) was not required for this retrospective study as it involved the analysis of fully anonymized data, with no identifiable patient information.This study did not involve any direct patient contact, intervention or changes to standard clinical care. In accordance with local institutional and regulatory guidelines, research using anonymized retrospective data that does not pose risks to patient confidentiality or welfare is typically exempt from formal IRB review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}